135 results
Page 6 of 7
424B4
41565argno 4u
15 Jun 18
Prospectus supplement with pricing info
12:26pm
8-K
EX-3.1
cr3hbd14ow50rb3
29 May 18
ContraVir Pharmaceuticals to Present at 2018 BIO International Convention
4:29pm
8-K
EX-99.1
66ubz7l8f
24 May 18
ContraVir Pharmaceuticals, Inc. Announces Reverse Stock Split
4:15pm
10-KT
23lo1cw30r nrawm
26 Mar 18
Annual report (with FYE transition)
12:00am
424B5
zax 3unszwrw80ene5
24 Apr 17
Prospectus supplement for primary offering
12:00am
424B5
z6bxwxawdhz93pyg
7 Oct 15
Prospectus supplement for primary offering
12:00am
8-K
EX-4.1
6ryq tnw788q
7 Oct 15
Contravir Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock and Warrants to Purchase Common Stock
12:00am
8-K
EX-1.1
in3l 1adle3u9jm
7 Oct 15
Contravir Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock and Warrants to Purchase Common Stock
12:00am
8-K
EX-10.1
2sm7gia519n7s o3oa
15 Jan 15
ContraVir Pharmaceuticals Appoints John Sullivan-Bolyai, M.D., MPH, as Chief Medical Officer
12:00am
DEF 14A
gr4z18r
27 Oct 14
Definitive proxy
12:00am
PRER14A
x7r8dq41
23 Oct 14
Preliminary revised proxy
12:00am
10-K
yru3yicvt7nni65cwstl
29 Sep 14
Annual report
12:00am